DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories
02 4Alfred E Tiefenbacher GmbH
03 2Pharmathen SA
04 1Towa Pharmaceutical
05 5A. Menarini
06 2AMN Life Science
07 1Abacus Medicine
08 2Accord healthcare
09 2Aeron Remedies
10 6Akriti Pharmaceuticals Pvt. Ltd.
11 4Alembic Pharmaceuticals Limited
12 2Alkem Laboratories
13 2Aristo Pharma GmbH
14 2Asian Pharmaceuticals
15 4Aurobindo Pharma Limited
16 2BEIJING SL PHARMACEUTICAL
17 2Bluepharma
18 2CHEMO
19 2CTSRL PHARMACEUTICAL LABORATORY
20 2Celogen Pharma Pvt. Ltd
21 1DIFARMED S.L.
22 2DOC Generici
23 2DYMALIFE PHARMACEUTICAL SRL
24 2EG Spa
25 1Eqova
26 2Global Napi Pharmaceuticals
27 2Gracure Pharmaceuticals Limited
28 2Hikma Pharmaceuticals
29 4Indoco Remedies Limited
30 1JAMP PHARMA
31 2Jiangsu Hengrui Medicine
32 2Kolmar Korea Co., Ltd.
33 2Krka
34 2Lanova Farmaceutici
35 2Lucent Biotech Ltd
36 2Lupin Ltd
37 2MSN Laboratories
38 4Macleods Pharmaceuticals Limited
39 6Menarini
40 1NATIONAL BIOCHEMISTRY INSTITUTE SAVIO SRL
41 3Neopharma
42 2Pantson Pharma Pvt. Limited
43 2Precise Group
44 2Prinston
45 2S.R. Drug Laboratories
46 4SF Group
47 2Sandoz B2B
48 3Saudi Pharmaceutical Industries & Medical Appliances
49 3Scott-Edil Pharmacia
50 2Smith & Kenner Pharmaceuticals
51 2So.Se.Pharm
52 2Sudha Life Sciences
53 2Sun Pharmaceutical Industries Limited
54 2Sunshine Lake Pharma
55 2Takeda Pharmaceutical
56 3Tecnimede
57 2Teva Pharmaceutical Industries
58 7Torrent Pharmaceuticals Limited
59 4Viatris
60 2Wanbang Biopharmaceuticals
61 2Zentiva
62 1Zota Healthcare Ltd
63 2Zydus Lifesciences
01 2FILM COATED PILL
02 1Febuxostat 120Mg 28 Combined Oral Use
03 1Febuxostat 80Mg 28 Combined Oral Use
04 14Film Coated Tablet
05 4Film-Coated Tablet
06 2Film-Coated Tablet Oral Use Blister
07 1Film-Coated Tablet Oral Use Bottle
08 32Film-Coated Tablets
09 2Film-Coated Tablets 28
10 2Fim Coated Tablet
11 10TABLET
12 34TABLET;ORAL
13 42Tablet
14 1Tablet, film-coated
15 3Tablets
16 2Blank
01 6DISCN
02 2EU Approved
03 11Generic
04 2Generic US CTD
05 1Prescription
06 26RX
07 4Registered in EU
08 101Blank
01 5ADENURIC
02 2ALPHABUX
03 1ARBUX
04 8Adenuric
05 3Agout
06 2DYMAURIC
07 1F-STAT 40
08 1F-STAT 80
09 2FEBISULE
10 2FEBUPHAR-40
11 1FEBUPHAR-80
12 1FEBURON 40
13 1FEBURON 80
14 2FEBUXEN
15 32FEBUXOSTAT
16 2FEBUXOSTAT ACCORD
17 2FEBUXOSTAT ARISTO
18 2FEBUXOSTAT AUROBINDO
19 2FEBUXOSTAT DOC GENERIC
20 2FEBUXOSTAT EG
21 2FEBUXOSTAT KRKA
22 2FEBUXOSTAT SANDZ
23 1FEBUXOSTAT TECNIGEN
24 2FEBUXOSTAT TEVA
25 1FEBUXOSTAT THINK
26 2FEBUXOSTAT VIATRIS
27 2FEBUXOSTAT ZENTIVA ITALY
28 1Feburic 40
29 1Feburic 80
30 2Febuxt Tablet
31 3Fiburik
32 2GAUTI
33 2GOTTART
34 2Goutifade
35 1JAMP FEBUXOSTAT
36 2ULORIC
37 2URIQUID
38 49Blank
01 2Australia
02 1Canada
03 4China
04 2Egypt
05 4Germany
06 2Greece
07 36India
08 40Italy
09 4Nepal
10 1Norway
11 4Portugal
12 2South Korea
13 2Spain
14 2Sweden
15 3Switzerland
16 3U.A.E
17 34USA
18 4United Kingdom
19 3Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : FEBUXOSTAT
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2020-10-22
Application Number : 205374
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 80MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 80MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info :
Registration Country : Italy
Brand Name : FEBUXOSTAT THINK
Dosage Form : Film-Coated Tablets
Dosage Strength : 80 mg
Packaging : 28 UNITS 80 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : FEBUXOSTAT
Dosage Form : TABLET;ORAL
Dosage Strength : 80MG
Packaging :
Approval Date : 2020-10-22
Application Number : 205374
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 120MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 80MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 120MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 120MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : RX
Registration Country : USA
Brand Name : FEBUXOSTAT
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2019-07-01
Application Number : 205421
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FEBUXOSTAT
Dosage Form : TABLET;ORAL
Dosage Strength : 80MG
Packaging :
Approval Date : 2019-07-01
Application Number : 205421
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FEBUXOSTAT
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2019-10-15
Application Number : 205414
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FEBUXOSTAT
Dosage Form : TABLET;ORAL
Dosage Strength : 80MG
Packaging :
Approval Date : 2019-10-15
Application Number : 205414
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FEBUXOSTAT
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2024-01-17
Application Number : 205406
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FEBUXOSTAT
Dosage Form : TABLET;ORAL
Dosage Strength : 80MG
Packaging :
Approval Date : 2024-01-17
Application Number : 205406
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ULORIC
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2009-02-13
Application Number : 21856
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ULORIC
Dosage Form : TABLET;ORAL
Dosage Strength : 80MG
Packaging :
Approval Date : 2009-02-13
Application Number : 21856
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FEBUXOSTAT
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2019-07-01
Application Number : 205385
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FEBUXOSTAT
Dosage Form : TABLET;ORAL
Dosage Strength : 80MG
Packaging :
Approval Date : 2019-07-01
Application Number : 205385
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FEBUXOSTAT
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2023-01-09
Application Number : 205443
Regulatory Info : RX
Registration Country : USA
LOOKING FOR A SUPPLIER?